###begin article-title 0
Glucocorticoids can activate the alpha-ENaC gene promoter independently of SGK1
###end article-title 0
###begin p 1
###xml 130 131 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 393 395 381 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1547 1549 1502 1504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
The role of SGK1 (serum- and glucocorticoid-induced protein kinase 1) in the glucocorticoid induction of alpha-ENaC (epithelial Na+ channel alpha subunit) gene transcription was explored by monitoring the transcriptional activity of a luciferase-linked, alpha-ENaC reporter gene construct (pGL3-KR1) expressed in H441 airway epithelial cells. Dexamethasone evoked a concentration-dependent (EC50approximately4 muM) increase in transcriptional activity dependent upon a glucocorticoid response element in the alpha-ENaC sequence. Although dexamethasone also activated endogenous SGK1, artificially increasing cellular SGK1 activity by expressing a constitutively active SGK1 mutant (SGK1-S422D) in hormone-deprived cells did not activate pGL3-KR1. Moreover, expression of catalytically inactive SGK1 (SGK1-K127A) suppressed the activation of endogenous SGK1 without affecting the transcriptional response to dexamethasone. Increasing cellular PI3K (phosphoinositide 3-kinase) activity by expressing a membrane-anchored form of the catalytic PI3K-P110alpha subunit [CD2 (cluster of differentiation 2)-P110alpha] also activated endogenous SGK1 without affecting pGL3-KR1activity. A catalytically inactive form of CD2-P110alpha (R1130P), on the other hand, prevented the dexamethasone-induced activation of SGK1, but did not inhibit the activation of pGL3-KR1. However, expression of SGK1-S422D or CD2-P110alpha enhanced the transcriptional responses to maximally effective concentrations of dexamethasone and this effect occurred with no change in EC50. Dexamethasone-induced (0.3-300 nM) activation of pGL3-KR1 was unaffected by inhibitors of PI3K (PI-103 and wortmanin) and by rapamycin, a selective inhibitor of the TORC1 (target of rapamycin complex 1) signalling complex. Dexamethasone-induced activation of the alpha-ENaC gene promoter can thus occur independently of SGK1/PI3K, although this pathway does provide a mechanism that allows this transcriptional response to dexamethasone to be enhanced.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 469 470 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 502 503 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 619 620 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 621 622 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 657 658 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1139 1140 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1141 1142 1123 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1241 1242 1223 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1243 1245 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1445 1446 1427 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1483 1484 1465 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1497 1498 1479 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1499 1500 1481 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1766 1767 1744 1745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1780 1782 1758 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1783 1785 1761 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1938 1940 1912 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 2055 2056 2029 2030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2201 2206 <span type="species:ncbi:9606">human</span>
The integrated functioning of the respiratory tract is dependent upon the controlled absorption of Na+ from the liquid film that covers the lung/airway epithelia, and glucocorticoid hormones are important to the induction and maintenance of this Na+-absorbing phenotype [1-3]. Epithelial Na+ absorption occurs via a 'leak-pump' mechanism [4], in which the overall rate of Na+ absorption is restricted by the rate of apical Na+ entry, and this rate-limiting influx of Na+ occurs via ENaCs (epithelial Na+ channels), transport proteins composed of three subunits (alpha-, beta- and gamma-ENaC) encoded by separate genes [5,6]. In unstimulated cells, apical Na+ permeability appears to be restricted by the continual internalization of ENaC, and this process is mediated by Nedd-4/2 (neural precursor cell expressed, developmentally down-regulated protein 4-2), an ubiquitin ligase that binds to WW domains (protein-protein interaction modules characterized by two conserved proline residues spaced 20-22 amino acids apart) on beta- and gamma-ENaC, thus targeting the ENaC channel complex for ubiquitination, internalization and degradation [7,8]. Glucocorticoids induce expression of SGK1 (serum- and glucocorticoid-induced protein kinase 1) [9,10], a regulatory kinase that phosphorylates Nedd-4/2, thus blocking this protein's interaction with ENaC. Activating SGK1 therefore allows ENaC to remain in the apical membrane, leading to a rise in Na+ permeability and a stimulation of Na+ absorption [7,8]. However, glucocorticoid hormones also control alpha-ENaC transcription by activating a GRE (glucocorticoid receptor response element) in this gene's promoter region, and this provides another mechanism that allows these hormones to contribute to the control of Na+ absorption [11-13]. It is therefore interesting that studies of renal epithelia have indicated that SGK1 may also play a role in the control of alpha-ENaC transcription [14]. Since this may have implications for our understanding of the ways in which glucocorticoids control pulmonary Na+ transport, the present study explores the relationship between cellular SGK1 activity and alpha-ENaC transcription in glucocorticoid-stimulated human airway epithelial cells.
###end p 3
###begin title 4
EXPERIMENTAL
###end title 4
###begin title 5
Cell culture and molecular biology
###end title 5
###begin p 6
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 221 222 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 254 255 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 323 325 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 452 453 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 465 467 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 543 545 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 693 694 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 742 743 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1050 1053 1039 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
###xml 1287 1289 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1290 1292 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1369 1371 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1563 1565 1552 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 2168 2170 2133 2135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 1793 1796 <span type="species:ncbi:10116">rat</span>
Experiments were undertaken using a human distal airway epithelial cell line (H441) that expressed an endogenous Na+ conductance essentially identical with that associated with alpha-, beta- and gamma-ENaC co-expression [6]. Since the activity of this Na+ conductance is strictly dependent upon glucocorticoid stimulation [15], these cells provide a valuable experimental system with which to explore the factors that allow these hormones to control Na+ transport [15]. Standard techniques were used to maintain these cells in serial culture [16], and experiments were undertaken using cells removed from culture flasks using trypsin/EDTA and plated on to 24-well (reporter gene assays, 7.5x104 cells/well) or six-well (Western analysis, 3x105 cells/well) plates. Cellular SGK1 activity was artificially increased by transfecting cells with a cDNA construct encoding a glutathione transferase-fusion protein incorporating a truncated form of SGK1 which lacked 60 N-terminal amino acid residues and which had been further modified by mutating SGK1-Ser422 to aspartate (SGK1-S422D). The N-terminal truncation increases the expression of this protein by preventing its degradation, and the S422D mutation allows SGK1 to be activated by PDK1 (3-phosphoinositide-dependent protein kinase 1) [10,18]. Taken together, these mutations confer a constitutively active phenotype [18]. Non-specific effects of the transfection and/or heterologous protein expression were controlled for using an analogous construct encoding a catalytically inactive form of SGK1, SGK1-K127A [18]. The role of PI3K (phosphoinositide 3-kinase) was explored by expressing a chimaeric protein consisting of the catalytic P110alpha domain of PI3K (PI3K-P110alpha) attached to the extracellular and transmembrane domains of the rat CD2 surface antigen. The CD2 domain effectively anchors the PI3K-P110alpha subunit to the inner surface of the membrane. PI3K activity was enhanced using a construct encoding wild-type PI3K-P110alpha (CD2-P110alpha), and the corresponding control construct (CD2-P110alpha-R1130P) incorporated a catalytically inactive mutant. This system has been detailed previously in [19].
###end p 6
###begin title 7
Transcriptional activity of the alpha-ENaC promoter
###end title 7
###begin p 8
###xml 532 534 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 535 537 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 705 707 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1489 1491 1460 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1492 1494 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Activation of the promoter region of the alpha-ENaC gene was assayed by transfecting cells on 24-well plates using Lipofectaminetrade mark 2000 with a luciferase-linked reporter gene construct (pGL3-KR1) incorporating 2.2 kb of the alpha-ENaC gene sequence corresponding to nucleotides -1388 to +830 relative to the start site for the alpha-ENaC-1 transcript. This gene sequence includes exon 1A, intron 1, the start site for the alpha-ENaC-2 transcript and the GRE at position -141 to -155 that is known to regulate transcription [12,13]. In all experiments the transfected cells were initially maintained (24 h) in a fully defined culture medium prepared using dialysed serum devoid of glucocorticoids [16]. Glucocorticoid-deprived cells were exposed to this medium throughout the entire experimental period, whereas dexamethasone-stimulated cells were exposed to this synthetic glucocorticoid as detailed below. Experiments were terminated by lysing the cells so that luciferase formation could be quantified (Wallac 1420 Victor plate reading luminometer/Promega luciferase assay system) and normalized to the amount of cellular protein in each well, which was determined using Bradford reagent. Some experiments were undertaken using a reporter construct that had been modified by deleting (Stratagene QuikChange II site-directed mutagenesis kit) five nucleotides (position -150 to -155) in order to disrupt the GRE that has previously been documented in the alpha-ENaC gene promoter [12,13].
###end p 8
###begin title 9
Experimental design and data analysis
###end title 9
###begin p 10
###xml 1006 1008 1006 1008 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1038 1039 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1039 1042 1039 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1314 1315 1314 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1343 1348 1343 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Param</italic>
###xml 1348 1349 1348 1349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1354 1359 1354 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Param</italic>
###xml 1359 1360 1359 1360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1435 1437 1435 1437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1441 1442 1441 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1442 1445 1442 1445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1451 1453 1451 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SE</italic>
###xml 1453 1454 1453 1454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1459 1461 1459 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SE</italic>
###xml 1461 1462 1461 1462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1696 1697 1696 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1834 1835 1834 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1922 1923 1922 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1974 1975 1974 1975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
All pGL3-KR1 activities were expressed as fold increases over the basal activity measured in cells expressing the empty pGL3 vector (pGL3-basic). Hormone-sensitive pGL3-KR1 activity was quantified by subtracting the activity measured in glucocorticoid-deprived cells from the activity measured in dexamethasone-stimulated cells, and all such data are shown as percentages of the activity measured in cells exposed to a maximally effective concentration of dexamethasone. To allow comparison between different data sets, the response to this standard stimulus was quantified in every experiment. Plots showing the relationship between hormone-sensitive pGL3-KR1 activity and dexamethasone concentration were constructed and sigmoid curves fitted to the pooled data by least-squares regression. Since the background activity was defined experimentally, the algorithm used to fit this curve (Grafit 5; Erithacus Software) estimated (i) the concentration of dexamethasone needed for half-maximal activation (EC50); (ii) the maximal response (Rmax), and (iii) the Hill Coefficient. This software package also provided an estimate of the standard error associated with each parameter and the statistical significance of any apparent differences between data sets could thus be tested by calculating a value of Student's t using the equation:  where Param1 and Param2 are the respective parameters measured under different conditions (i.e. EC50 or Rmax) and SE1 and SE2 represent their respective standard errors. Each curve was defined by six or seven different dexamethasone concentrations and was therefore fitted with three or four df (degrees of freedom). This, in turn, implies that the values of t derived from this equation are associated with six or eight df, and these were therefore used to estimate the two-tailed probabilities (P) that the two parameters are derived from the same statistical populations. Values of P<0.05 were considered to be significant. Values of n denote the number of times a protocol was repeated using cells at different passage number and all results are means+/-S.E.M.
###end p 10
###begin title 11
Assay of SGK1 activity
###end title 11
###begin p 12
###xml 149 160 149 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1221 1223 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Changes in cellular SGK1 activity were monitored using phosphospecific antibodies to monitor by Western analysis the phosphorylation of residues (Thr346/356/366) within an endogenous protein (NDRG1; N-myc-downstream gene 1) that are phosphorylated by SGK1 but not by other kinases, including the closely related PKB (protein kinase B) [20-22]. Although it is now clear that changes to the phosphorylation status of these residues can provide a read-out of cellular SGK1 activity (see e.g. [22,23]), our experience is that there can be variations in the magnitudes of the responses measured in different experiments. To ensure that this effect did not confound analysis of the present data, all experiments were undertaken using strictly paired experimental designs in which the control and experimental cells were age-matched and at identical passage. Great care was taken to handle all protein samples identically and, in all experiments, proteins extracted from control and experimental cells were processed in parallel using identical reagents and then fractionated on the same gels so that they could be analysed in exactly the same way. A full account of this method [22], and a detailed review of its rationale [20,21], are published elsewhere.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin title 14
Glucocorticoid-induced activation of the alpha-ENaC gene promoter
###end title 14
###begin p 15
###xml 120 121 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 126 127 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 153 154 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 621 629 590 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 751 759 720 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 939 941 908 910 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 976 984 943 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1042 1044 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1389 1397 1356 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1592 1594 1555 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1595 1597 1558 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
When expressed in glucocorticoid-deprived cells, the activity of the pGL3-KR1 reporter gene was 7.3+/-1.0-fold greater (n=49, P<0.0001, Student's paired t test) than the activity measured in cells expressing the empty pGL3 vector. Dexamethasone (0.1 muM) consistently evoked luciferase synthesis in pGL3-KR1-expressing cells and, since this response was not seen in cells expressing the empty vector (results not shown), this finding confirms that this synthetic glucocorticoid normally activates the alpha-ENaC gene promoter. This response became apparent after approximately6 h, reached a plateau at approximately18 h (Figure 1A) and was abolished by disrupting the GRE that has previously been shown to regulate the activity of this gene promoter (Figure 1A). Experiments in which luciferase formation was quantified in cells exposed to 0.3-300 nM dexamethasone for 18 h showed that this response was concentration-dependent, and the EC50 was estimated to be 3.7+/-0.4 nM (Figure 1B), a value similar to that reported in a previous study [25]. Concentrations of dexamethasone >30 nM usually evoked maximal responses, although, in some experiments, high concentrations of dexamethasone evoked sub-maximal responses, indicating that this response can be subject to desensitization. The activation of this reporter gene was abolished by mifepristone, a glucocorticoid receptor antagonist (Figure 1B), and it is therefore clear that this response reflects glucocorticoid receptor-mediated activation of the GRE that has been previously described in the promoter region of the alpha-ENaC gene [11-13].
###end p 15
###begin title 16
Dexamethasone-induced activation of pGL3-KR1
###end title 16
###begin p 17
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 176 177 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 281 282 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 288 289 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 433 434 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 483 484 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(A) Time courses showing the effects of dexamethasone (0.1 muM) upon luciferase accumulation in cells expressing either wild-type (wt) alpha-ENaC reporter construct (pGL3-KR1, n=10) or the construct incorporating the mutant alpha-ENaC sequence lacking the functional GRE (GRE-del, n=5). (B) Concentration-effect curves showing the effects of dexamethasone (18 h) upon the activity of pGL3-KR1 activity both under control conditions (n=8) and in the presence of 2.5 muM mifepristone (n=8).
###end p 17
###begin title 18
###xml 38 49 38 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
SGK1-induced phosphorylation NDRG1-Thr346/356/366
###end title 18
###begin p 19
###xml 218 229 217 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 311 319 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 425 427 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 637 648 636 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 786 794 785 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 911 919 910 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1015 1026 1014 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 1164 1175 1163 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 1186 1194 1185 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1212 1223 1211 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 1261 1263 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1291 1293 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
Western blot analyses of protein extracted from unstimulated and dexamethasone-treated (0.1 muM, 18 h) cells expressing the empty pGL3 vector showed that this synthetic glucocorticoid increased the abundance of the Thr346/356/366-phosphorylated NDRG1 with no effect upon the overall expression of this protein (Figure 2). This response was essentially identical with that reported in previous studies of untransfected cells [22] and it is therefore clear that exposure to transfection reagents does not alter this response. Parallel studies of glucocorticoid-deprived cells expressing SGK1-S422D revealed a clear stimulation of NDRG1-Thr346/356/366 phosphorylation and this response, in common with the response to dexamethasone, occurred with no change in the overall NDRG1 abundance (Figure 2). Dexamethasone stimulation had no further effect upon the phosphorylation of NDRG1 in SGK1-S422D-expressing cells (Figure 2). Transient expression of SGK1-K127A had no effect upon the phosphorylation status of NDRG1-Thr346/356/366 in dexamethasone-deprived cells, but this catalytically-inactive form of SGK1 suppressed the dexamethasone-induced phosphorylation of Thr346/356/366 in NDRG1 (Figure 2). Since NDRG1-Thr346/356/366 residues are phosphorylated by SGK1 [20], these results (see also [22]) show that this catalytically inactive form of SGK1 suppresses the hormonal activation of this kinase.
###end p 19
###begin title 20
Activation of SGK1
###end title 20
###begin p 21
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 412 423 410 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 498 499 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A) Control (i.e. cells transfected with empty vector; Cont.) cells and cells transiently expressing either SGK1-S422D or SGK1-K127A were maintained in hormone-free medium or stimulated with 0.1 muM dexamethasone (Dex) for 18 h. All cells were then lysed and 15 mug aliquots of cellular protein were fractionated by SDS/PAGE, blotted on to Hibond membranes which were then probed using antibodies against the Thr346/356/366 phosphorylated form of NDRG1 (upper panel) or total NDRG1 (lower panel). (B) Densitometric analysis showing the pooled (means+/-S.E.M.) from six independent experiments. Unstim., unstimulated; Dex., dexamethasone.
###end p 21
###begin title 22
SGK1-induced activation of pGL3-KR1
###end title 22
###begin p 23
###xml 443 451 431 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 537 545 525 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 659 667 647 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 746 754 734 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 887 889 875 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1037 1045 1023 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1088 1089 1074 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1089 1092 1075 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1532 1540 1516 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1557 1558 1541 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1558 1561 1542 1545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1621 1622 1603 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1635 1636 1617 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1746 1748 1728 1730 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
To explore the role of SGK1 in the transcriptional response to dexamethasone, we assayed the transcriptional activity of pGL3-KR1 in control cells (i.e. cells expressing the empty vector) and in cells transiently expressing SGK1-S422D and SGK1-K127A. Analysis of data derived from glucocorticoid-deprived cells showed that the basal activity of pGL3-KR1 was approximately9-fold greater than the activity associated with the empty pGL3 vector (Figure 3A). SGK1-S422A-expressing cells displayed an essentially identical level of activity (Figure 3A) and, although the basal activity measured in cells expressing SGK1-K127A appeared slightly lower than control (Figure 3A), this effect was not statistically significant (one-way ANOVA). The data in Figure 3(B) show that dexamethasone normally caused concentration-dependent activation of pGL3-KR1 in SGK1-K127A-expressing cells, and the EC50 measured under these conditions (4.7+/-0.5 nM), did not differ significantly from that measured in age-matched control cells at identical passage (Figure 3B). The maximal response to dexamethasone (Rmax) was also essentially identical (93.6+/-2.8%) with the control, and so the expression of this inactive SGK1 mutant has no discernible effect upon the transcriptional response to dexamethasone. Analysis of the data derived from SGK1-S422D-expressing cells showed that this constitutively active mutant had no effect upon the responses to low concentrations of dexamethasone, but enhanced the responses to the highest concentrations tested (Figure 3B). The value of Rmax measured in these cells (188+/-13%) was therefore greater (t=7.28, df=8, P<0.0001) than the value measured in SGK1-K127A-expressing cells, and this effect occurred with no change in EC50 (5.9+/-1.6 nM).
###end p 23
###begin title 24
Role of SGK1 in alpha-ENaC transcription
###end title 24
###begin p 25
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 266 267 262 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 440 441 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(A) Luciferase formation (18 h, n=9) was quantified in hormone-deprived cells co-expressing the alpha-ENaC reporter gene in conjunction with SGK1-S422D or SGK1-K127A; control (Cont.) cells expressed this reporter gene construct together with the empty pEGB vector. (B) Dexamethasone-induced (18 h) activation of pGL3-KR1 in control cells (i.e. cells expressing pGL3-KR1 and pEGB) and in cells co-expressing either SGK1-S442D or SGK1-K127A (n=8). The continuous curves were fitted to the experimental data by least-squares regression. All results are normalized to the luciferase formation measured in cells expressing the empty pGL3 vector and are shown as means+/-S.E.M.
###end p 25
###begin title 26
###xml 22 33 22 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
PI3K-induced NDRG1-Thr346/356/366 phosphorylation
###end title 26
###begin p 27
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 67 78 67 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 327 329 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 531 533 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 534 536 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 599 610 590 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 814 822 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 910 921 901 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 957 965 944 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1111 1122 1090 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 1294 1302 1273 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1376 1378 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1379 1381 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1577 1585 1552 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
Figure 4 shows the results of experiments that quantified NDRG1-Thr346/356/366 phosphorylation in glucocorticoid-deprived and dexamethasone-stimulated cells transiently expressing the chimaeric proteins incorporating the catalytic PI3K-P110alpha subunit. Results derived from control cells confirmed (in the present study and [22]) that dexamethasone (0.1 muM, 18 h) evokes the phosphorylation of these residues with no effect upon the overall NDRG1 abundance, confirming that glucocorticoids normally increase SGK1 activity (see [20,22]). Transient expression of CD2-P110alpha also evoked NDRG1-Thr346/356/366 phosphorylation with no effect upon the overall expression, indicating that artificially increasing cellular PI3K activity mimics the effects of glucocorticoid stimulation by activating endogenous SGK1 (Figure 4). Dexamethasone stimulation had no further effect upon the phosphorylation of NDRG1-Thr346/356/366 in CD2-P110alpha-expressing cells (Figure 4). Expression of CD2-P110alpha-R1130, which incorporates a catalytically inactive form of the PI3K-P110alpha subunit, had no effect upon NDRG1 Thr346/356/366 phosphorylation in glucocorticoid-deprived cells, but prevented the increased phosphorylation of these residues that was normally seen in glucocorticoid-stimulated cells (Figure 4). Since PI3K is known to control the phosphorylation/activation of SGK1 [18,26], the results from the present study indicate that the transient expression of CD2-P110alpha-R1130 exerts a dominant-negative effect by suppressing the glucocorticoid-induced activation of SGK1 (Figure 4).
###end p 27
###begin title 28
Effects of increasing cellular PI3K activity
###end title 28
###begin p 29
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 365 376 355 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 481 482 471 472 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A) Control cells (i.e. cells transfected with empty vector; Cont.) and cells transiently expressing either CD2-P110alpha or CD2-P110alpha-R1130P were either maintained in hormone-free medium or stimulated with 0.1 muM dexamethasone (Dex) for 18 h. All cells were then lysed and 15 mug aliquots of cellular protein fractionated so that the cellular abundance of Thr346/356/366-phosphorylated NDRG1 (upper panel) and total NDRG1 (lower panel) could be assayed by Western analysis. (B) Densitometric analysis showing the pooled means+/-S.E.M. from ten independent experiments. Unstim., unstimulated; Dex., dexamethasone; wt, wild-type.
###end p 29
###begin title 30
PI3K-induced activation of pGL3-KR1
###end title 30
###begin p 31
###xml 153 155 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 276 284 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 527 535 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1227 1228 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1228 1231 1192 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1245 1253 1207 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1282 1283 1244 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1377 1378 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1378 1381 1340 1343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1471 1472 1429 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1485 1486 1443 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Experiments in which the activity of the alpha-ENaC reporter gene construct was monitored in hormone-deprived cells confirmed (in the present study and [25]) that the basal activity of this construct is approximately10-fold greater than that associated with the empty vector (Figure 5A). Initial examination of the results of experiments in which transcriptional activity was quantified in cells expressing CD2-P110alpha or CD2-P110alpha-R1130P suggested that the expression of these chimaeric proteins might inhibit pGL3-KR1 (Figure 5A). However, these apparent effects did not reach statistical significance (one-way ANOVA), and so neither construct has any direct effect upon the transcriptional activity of the promoter region of the alpha-ENaC gene. These experiments also explored the effects of dexamethasone (18 h, 1-300 nM) upon pGL3-KR1 activity in cells expressing these chimaeric proteins. As anticipated, studies of control cells confirmed that this hormone normally induces concentration-dependent activation of the alpha-ENaC gene promoter (see above). Although this response was also seen in CD2-P110alpha-R1130P-expressing cells, analysis of these results indicated that the maximal response to dexamethasone (Rmax=1.84+/-0.06, Figure 5B) was greater than control (P<0.05). However, the most important result to emerge from these studies was that the value of Rmax measured in cells expressing the catalytically active CD2-P110alpha protein was greater (t=8.11, df=4, P<0.0001) than the maximal response measured in cells expressing CD2-P110alpha-R1130P. It is therefore clear that increasing cellular PI3K activity enhances the dexamethasone-induced activation of the alpha-ENaC reporter gene construct.
###end p 31
###begin title 32
Role of PI3K in alpha-ENaC transcription
###end title 32
###begin p 33
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 39 47 39 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 232 233 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 377 378 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(A) The experimental protocol shown in Figure 3 was used to monitor the transcriptional activity of pGL3-KR1 in hormone-deprived control (Cont.) cells and in expressing either CD2-P110alpha (wild-type, wt) or CD2-P110alpha-R1130P. (B) Dexamethasone-induced (18 h) activation of pGL3-KR1 in control cells and in cells expressing either CD2-P110alpha-wt or CD2-P110alpha-R1130P (n=9). The continuous curves were fitted to the experimental data by least-squares regression. All data are normalized to the luciferase formation measured in cells expressing the empty pGL3 vector and are shown as means+/-S.E.M.
###end p 33
###begin title 34
Effects of cell stress
###end title 34
###begin p 35
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 574 575 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 576 577 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 722 723 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 818 829 812 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 979 988 973 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 994 995 988 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 1251 1259 1241 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
As well as being induced by glucocorticoid hormones, data from several different cell types show that SGK1 activity/expression is enhanced by stressful stimuli [9,27-31], and we therefore explored the effects of such stimuli on SGK1 activity in H441 cells. Initial studies (n=5) showed that 2 h exposure to a hyperosmotic external solution (prepared by adding 300 mM sorbitol to the standard culture medium) had no effect upon NDRG1 phosphorylation assayed after a 12 h recovery period. Similarly exposing cells (n=4) to increased ambient temperature (42 degreesC, 1 h) or H2O2 (0.5 mM, 1-2 h) also had no effect upon the phosphorylation of these residues. However, exposing cells to a brief <1 s pulse of UV light (50 J.m2; Spectronic Corporation Spectrolinker) consistently increased the phosphorylation of NDRG1-Thr346/356/366 assayed after a 2 h recovery period, and this stimulus therefore provides a way of activating endogenous SGK1 independently of stimulating hormones (Figures 6A and 6B). However, subsequent experiments showed that irradiating the cells with UV light in this way had no direct effect upon the transcriptional activity of the alpha-ENaC gene promoter and also failed to modify the transcriptional response to dexamethasone (Figure 6C).
###end p 35
###begin title 36
###xml 63 74 63 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
Effects of UV irradiation upon the phosphorylation of NDRG1-Thr346/356/366 and the activity of the alpha-ENaC reporter gene construct
###end title 36
###begin p 37
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 129 140 128 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 190 191 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 389 390 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 419 420 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 458 459 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 754 755 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(A) Western blots showing the effects of dexamethasone (Dex., 0.1 muM, 6 h) and UV irradiation upon the cellular abundance of Thr346/356/366-phosphorylated and total NDRG1. Cont., control. (B) Densitometric analysis showing the pooled means+/-S.E.M. from five independent experiments; asterisks denote statistically significant differences from the control (Cont.) value (Student's paired t test). Dex., dexamethasone (C) Results of a series of experiments (n=5) undertaken using a strictly paired experimental design that explored the effects of UV irrdiation upon the dexamethasone (Dex.) induced (0.1 muM, 6 h) activation of the alpha-ENaC reporter gene construct. Asterisks denote statistically significant effects of dexamethasone (Student's paired t test). Unstim., unstimulated.
###end p 37
###begin title 38
Effects of PI3K inhibitors
###end title 38
###begin p 39
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 239 241 238 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 368 369 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 383 384 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 434 442 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 498 500 481 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 584 592 563 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 778 780 757 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 907 915 882 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1263 1265 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1303 1305 1278 1280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1433 1434 1404 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1447 1448 1418 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1478 1486 1437 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
Figure 7 shows the results of experiments that used a strictly paired protocol to study the effects of PI3K inhibitors upon the dexamethasone-induced (0.3-100 nM) activation of pGL3-KR1. Although LY294002 (50 muM) had no effect upon the EC50 for dexamethasone (control: 3.4+/-0.4 nM; LY294002-treated: 3.2+/-0.5 nM), this substance caused approximately30% inhibition (t=13.41, df=6, P<0.0001) of the maximal response to this hormone (Figure 7A). Wortmannin, on the other hand, had no effect upon EC50 (control: 4.1+/-0.3 nM; wortmannin-treated: 6.4+/-3.8 nM) or the maximal response (Figure 7B). Although PI-103 appeared to cause a slight leftward shift in the concentration-response curve, this effect was not statistically significant and so this compound did not alter the EC50 (control: 3.7+/-0.09 nM; PI-103-treated: 2.1+/-0.1 nM). PI-103 also had no effect upon the magnitude of the maximal response (Figure 7C). Although LY294002, wortmannin and PI-103 are often used as selective inhibitors of PI3K, these compounds also inhibit TORC1, a signalling complex dependent upon mTOR (mammalian target of rapamycin) that controls many aspects of cellular physiology. We therefore also explored the effects rapamycin, an exquisitely selective inhibitor of TORC1 [32]. Rapamycin had no effect upon the EC50 for dexamethasone (control: 3.2+/-0.3 nM; rapamycin-treated: 3.2+/-0.5 nM), but enhanced the maximal response to this hormone (t=7.13, df=6, P=0.0004) by approximately75% (Figure 7D).
###end p 39
###begin title 40
Dexamethasone-induced activation of the alpha-ENaC gene promoter in cells treated with PI3K inhibitors or rapamycin
###end title 40
###begin p 41
###xml 224 225 223 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 227 228 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 254 255 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 257 258 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 279 280 276 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 282 283 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 309 310 306 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 312 313 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 582 583 578 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 585 586 581 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 591 592 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
All experiments were undertaken using a strictly paired protocol in which dexamethasone-induced (0.3-100 nM, 18 h) activation of pGL3-KR1 was monitored under control conditions and in the presence of either 50 muM LY294002 (A, n=13); 0.1 muM wortmannin (B, n=8); 0.5 muM PI-103 (C, n=8), or 100 nM rapamycin (D, n=12). All results were normalized to the control response evoked by a maximally effective concentration of dexamethasone. This usually occurred in response to 100 muM, but in some experiments this high concentration of hormone evoked a submaximal response (as shown in B, C and D) and in these experiments results were normalized to the response evoked by 30 nM dexamethasone. Results are shown as means+/-S.E.M. and sigmoid curves were fitted to the pooled data by least-squares regression.
###end p 41
###begin p 42
###xml 222 233 210 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 396 407 383 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 409 417 396 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 572 580 559 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 681 683 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 995 1003 982 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Figure 9</xref>
Analysis of protein extracted from glucocorticoid-deprived cells that had been maintained under control conditions or exposed to wortmannin/PI-103 showed that both substances reduced (approximately70%) the abundance of Thr346/356/366-phosphorylated NDRG1, with no effect upon the overall levels of NDRG1. As anticipated, dexamethasone (0.1 muM) normally increased the phosphorylation of NDRG1-Thr346/356/366 (Figure 8) and, although there was some evidence of a residual response in the wortmannin/PI-103-treated cells, this effect did not reach statistical significance (Figure 8). These experiments also explored the effects of LY294002 and, as anticipated by our previous work [22], this compound caused essentially complete dephosphorylation of NDRG1 and totally abolished the response to dexamethasone. Further experiments showed that rapamycin had no significant effect upon the phosphorylation status of these residues in either glucocorticoid-deprived or dexamethasone-stimulated cells (Figure 9).
###end p 42
###begin title 43
###xml 62 73 62 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
Effects of PI3K inhibitors on the phosphorylation of NDRG1-Thr346/356/366
###end title 43
###begin p 44
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 125 136 123 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 341 342 338 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 528 529 523 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
(A) Western blots showing the effects of wortmannin (Wort.) (0.1 muM) and PI-103 (0.5 muM) upon the cellular abundance of Thr346/356/366-phosphorylated and total NDRG1 in glucocorticoid-deprived and dexamethasone (Dex)-stimulated (0.1 muM) cells. This protocol was repeated five times using cells at different passage number. Cont. control (B) Results from a directly analogous experiment showing effects of PI-103 (0.5 muM) and LY294002 (Ly; 50 muM). This protocol was repeated five times. Dex, dexamethasone; Cont., control. (C) Densitometric analysis showing the pooled means+/-S.E.M. from all experiments. Unstim., unstimulated; Dex, dexamethasone; Cont., control; Wort., Wortmannin; LY, LY294002.
###end p 44
###begin title 45
###xml 58 69 58 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
Effects of rapamycin upon the phosphorylation of NDRG1-Thr346/356/366
###end title 45
###begin p 46
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 93 104 92 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 216 217 214 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A) Western blots showing the effects of rapamycin (0.1 muM) on the cellular abundance of Thr346/356/366-phosphorylated and total NDRG1 in glucocorticoid-deprived and dexamethasone (Dex)-stimulated (0.1 muM) cells. (B) Densitometric analysis showing the pooled means+/-S.E.M. from five independent experiments. Rap., rapamycin.
###end p 46
###begin title 47
DISCUSSION
###end title 47
###begin title 48
Dexamethasone-induced activation of the alpha-ENaC gene promoter
###end title 48
###begin p 49
###xml 291 293 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 294 296 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 297 299 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 300 302 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 303 305 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 441 443 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 444 446 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 447 449 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 450 452 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 453 455 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 756 758 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 906 908 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1009 1011 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1012 1014 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 255 258 <span type="species:ncbi:10116">rat</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
When expressed in glucocorticoid-deprived cells, the alpha-ENaC reporter gene construct displayed a level of activity 5-10-fold greater than that associated with the empty vector, and such low basal activity has been documented in previous studies of the rat and human alpha-ENaC promoters [11-13,25,33,34]. Dexamethasone consistently activated this reporter gene construct via a mechanism dependent upon the GRE in the alpha-ENaC promoter [11-13,25,33,34], and the fact that this response was abolished by mifepristone, a glucocorticoid receptor antagonist, provides further evidence for the involvement of these receptors. The response to dexamethasone was concentration-dependent and the half-maximal activation occurred at approximately4 nM (see also [25]). It is therefore interesting that the oral administration of 1 mg of dexamethasone increases the circulating concentration to approximately7 nM [35], whereas the intravenous administration of 5 mg leads to a circulating concentration of 50-100 nM [36,37]. These clinically relevant doses of dexamethasone therefore produce circulating concentrations sufficient to influence alpha-ENaC transcription and this response may therefore contribute to the clinical effects of this synthetic glucocorticoid.
###end p 49
###begin title 50
###xml 50 61 50 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
Dexamethasone-induced phosphorylation of NDRG1-Thr346/356/366
###end title 50
###begin p 51
###xml 71 82 71 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 621 623 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 624 626 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
Stimulation with dexamethasone also evoked phosphorylation of NDRG1-Thr346/356/366 and, since these residues are phosphorylated by SGK1 but not by other related kinases [20,21], this confirms that glucocorticoids activate SGK1 in these cells [10]. Our recently published data [22] show that this response peaks after approximately2 h, and the fact that elevated SGK1 activity is still evident after 18 h shows that the dexamethasone-induced activation of the alpha-ENaC promoter coincides with increased SGK1 activity, an observation consistent with the hypothesis that SGK1 is involved in this transcriptional response [14,38].
###end p 51
###begin title 52
Effects of SGK1-S422D/SGK1-K127A
###end title 52
###begin p 53
###xml 70 81 70 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 766 768 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
Expressing SGK1-S422D in glucocortcoid-deprived cells evoked NDRG1-Thr346/356/366 phosphorylation, and it is therefore clear that the expression of this constitutively active protein provides a way of increasing cellular SGK1 activity independently of stimulating hormones (see also [22]). However, despite this clear finding, expressing SGK1-S422D in glucocorticoid-deprived cells did not alter the activity of the alpha-ENaC gene promoter and it is therefore clear that a substantial increase in cellular SGK1 activity does not provide a stimulus sufficient to mimic the transcriptional response to dexamethasone. This was surprising, since previous studies of renal epithelia had indicated that SGK1 was important to the control of alpha-ENaC gene transcription [38]. However, our studies of dexamethasone-stimulated cells showed that SGK1-S422D expression enhanced the response to concentrations of dexamethasone >10 nM, and it is therefore clear that artificially imposed increases in cellular SGK1 activity can enhance the glucocorticoid-induced activation of the alpha-ENaC gene promoter under certain experimental conditions.
###end p 53
###begin p 54
###xml 131 142 131 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 588 599 588 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
Parallel studies of glucocorticoid-deprived cells expressing SGK1-K127 showed that this mutant protein had no effect upon NDRG1-Thr346/356/366 phosphorylation, and it is therefore clear that this catalytically inactive protein does not alter cellular SGK1 activity. The activation of SGK1 seen in cells expressing SGK1-S422D cannot, therefore, be attributed to increased activity of endogenous SGK1 evoked by exposure to transfection reagents and/or to the expression of heterologous protein. However, the expression of SGK1-K127A did block the dexamethasone-induced increase in NDRG1-Thr346/356/366 phosphorylation, and this catalytically inactive SGK1 mutant therefore seems to display a dominant-negative phenotype. Transient expression of this mutant protein therefore provides a way of disrupting the hormonal activation of endogenous SGK1 but, despite this clear finding, SGK1-K127A expression had no effect upon the transcriptional response to dexamethasone. Although increases in cellular SGK1 activity can augment the transcriptional response to dexamethasone (see above), it therefore appears that the hormonal activation of endogenous SGK1 is not necessary for the glucocorticoid-induced activation of the alpha-ENaC gene promoter.
###end p 54
###begin title 55
Effects of CD2-P110alpha/CD2-P110alpha-R1130P
###end title 55
###begin p 56
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 418 423 <span type="species:ncbi:9606">human</span>
Three isoforms of SGK have been identified in mammalian cells (SGK1-3) [27,39,40] and, although these share a high degree of homology in the catalytic domain, they differ in N-terminal structure. This variability is significant, since this region of SGK1 influences protein stability and cellular localization [18,41-43]. Moreover, although SGK1 is the only isoform that is hormone-sensitive, three splice variants of human SGK1 have been identified and these mRNA species encode proteins that also display different N-terminal sequences [44]. These SGK1 variants may therefore display different patterns of degradation and different cellular locations, and this heterogeneity may explain, at least in part, the diverse cellular functions of this kinase [10]. The fact that 60 N-terminal residues were deleted from the constitutively active form of SGK1 used in the present study implies that this modified protein is not degraded as rapidly as full-length SGK1 [18]. Moreover, this N-terminal deletion may also cause the SGK1-S422D protein to be located to an inappropriate cellular compartment and so, although SGK1-S422D can clearly increase cellular SGK1 activity, the transient expression of SGK1-S422 may not reproduce the effects of activating endogenous SGK1.
###end p 56
###begin p 57
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 356 358 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 458 469 454 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 537 539 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 540 542 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 543 545 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 546 548 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 752 763 744 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 1108 1109 1096 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1134 1136 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1137 1139 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
We therefore sought to identify a way of activating endogenous SGK1 independently of stimulating hormones and, since the catalytic activity of SGK1 is dependent upon PI3K-regulated phosphorylation [9,18,23,26], we explored the effects of transiently expressing a chimaeric protein encoding a membrane-anchored form of the catalytic PI3K-P110alpha subunit [19]. Expressing this PI3K-activating protein in glucocorticoid-deprived cells clearly evoked NDRG1-Thr346/356/366 phosphorylation, indicating increased activity of endogenous SGK1 [18,20,21,26]. Moreover, although a catalytically inactive control construct (CD2-P110alpha-R1130P) did not alter NDRG1 phosphorylation, this mutant protein did prevent the dexamethasone-induced increase in NDRG1-Thr346/356/366 phosphorylation, indicating that this chimaeric protein displays a dominant-negative phenotype. It is therefore interesting that electrophysiological studies undertaken in this laboratory (M. Gallacher and S.M. Wilson, unpublished work) have shown that the expression of CD2-P110alpha-R1130P can partially suppress the glucocorticoid-induced Na+ current in these cells [15,16]. Transient expression of CD2-P110alpha-R1130P thus seems to provide another way of blocking the glucocorticoid-induced activation of SGK1.
###end p 57
###begin p 58
Expressing these chimaeric proteins in glucocorticoid-deprived cells had no effect upon the transcriptional activity of the alpha-ENaC gene promoter, indicating that PI3K-mediated activation of SGK1 does not mimic the transcriptional response to dexamethasone. Interestingly, although it has no catalytic activity, expressing CD2-P110alpha-R1130P did enhance the transcriptional response to dexamethasone. Although this unexpected response to a catalytically inactive protein cannot be mediated via PI3K or SGK1, it is important to remember that this mutant protein would almost certainly suppress the phosphorylation of PI3K targets other than SGK1. It is therefore possible that a PI3K-dependent signalling pathway may normally exert inhibitory control over alpha-ENaC gene transcription. However, the most important result to emerge from these experiments was that expression of CD2-P110alpha augmented the transcriptional response to dexamethasone to a level greater than that measured in CD2-P110alpha-R1130P-expressing cells. This result accords well with the data derived from cells expressing the modified forms of SGK1 and, taken together, these two sets of independent experiments indicate that artificially imposed increases in cellular SGK1 activity do not mimic the effects of glucocorticoid stimulation but do enhance the transcriptional responses to these hormones.
###end p 58
###begin title 59
Pharmacological inhibition of PI3K
###end title 59
###begin p 60
###xml 533 535 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 536 538 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 711 713 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 714 716 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 717 719 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1150 1161 1122 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 1246 1248 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1249 1251 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1338 1340 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1364 1375 1336 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 1681 1683 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 2077 2079 2043 2045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1932 1938 <span type="species:ncbi:10090">murine</span>
Studies of cells expressing SGK1-K127A or CD2-P110alpha-R1130P showed that glucocorticoids continue to activate the alpha-ENaC promoter even if the activation of endogenous SGK1 is prevented and so, although SGK1 augments the transcriptional response to dexamethasone (see above), increased SGK1 activity does not seem to be necessary for the hormonal activation of the alpha-ENaC gene promoter. Since this contrasts with the situation in renal epithelia where SGK1 is intimately involved in the control of alpha-ENaC transcription [14,38], further experiments explored the effects of pharmacological inhibitors of PI3K, since such compounds characteristically cause a profound loss of SGK1 activity (see e.g. [18,22,23]). Neither wortmanin nor PI-103 had any effect upon the transcriptional response to dexamethasone, and although LY294002 reduced the maximal response to this hormone, this effect was relatively modest (approximately30% inhibition) and residual responses could clearly be seen in LY294002-treated cells. Parallel analyses of extracted protein showed that LY294002, PI-103 and wortmannin all reduced the phosphorylation of NDRG1-Thr346/356/366, indicating these substances all cause substantial inactivation of endogenous SGK1 [20,21]. However, although LY294002 appeared to cause a complete loss of activity (see also [22]), small amounts of Thr346/356/366-phosphorylated NDRG1 could still be detected in PI-103-treated and wortmannin-treated cells, suggesting that these compounds may not inactivate SGK1 fully. This discrepancy was surprising, since all three compounds were used at concentrations thought to cause complete inhibition of PI3K in intact cells [32], and it may be relevant that, as well as inhibiting PI3K, LY294002 is known to inactivate a number of protein kinases including GSK3beta (glycogen synthase kinase 3beta), PLK3 (polo-like kinase 3), CK2, PIM1 (provirus integration site for Moloney murine leukaemia 1) and PIM3, and it has been therefore suggested that the use of LY294002 as a selective PI3K inhibitor should be discontinued [32]. However, even if we accept that LY294002 is the only tested compound that was able to cause complete inhibition of PI3K, then the present data show that essentially complete loss of endogenous SGK1 activity causes only a modest reduction of the transcriptional response to dexamethasone.
###end p 60
###begin title 61
Effects of rapamycin
###end title 61
###begin p 62
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1021 1031 1017 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356366</sup>
###xml 1312 1315 1307 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 1429 1431 1424 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1599 1601 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1660 1663 1655 1658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
Although often referred to as PI3K inhibitors, LY294002, wortmannin and PI-103 also inhibit the TORC1 signalling complex [45,46], and this could be significant for the present study, since it has recently been proposed [47] that TORC1 catalyses the phosphorylation of SGK1-Ser422, implying that TORC1 plays an important role in the control of cellular SGK1 activity (see [18,26]). We therefore also explored the effects of rapamycin, since this compound has been shown to act as an exquisitely selective inhibitor of TORC1 [32]. The first such studies showed that rapamycin augmented the glucocorticoid-induced activation of the alpha-ENaC gene promoter, and it is therefore clear that the inhibitory action of LY294002 described above cannot be attributed to an effect on TORC1. Indeed, these data also suggest that tonic activity of TORC1 may normally repress the activity of this gene promoter. However, the most important result to emerge from these studies was that rapamycin had no discernible effect upon NDRG1-Thr346/356366 phosphorylation in glucocorticoid-deprived or dexamethasone-stimulated cells. Since separate experiments in this laboratory have shown that 2-3 h exposure to 0.1 muM rapamycin essentially abolishes TORC1 activity in H441 cells (assayed by monitoring the phosphorylation of S6K-Thr389; G. Watt and S.C. Land, personal communication) this result, in contrast with the data presented by Hong et al. [47], indicates that TORC1 is not important to the control of SGK1. This finding does, however, accord well with results recently presented by Garcia-Martinez and Alessi [23], who showed that the apparent phosphorylation of SGK1-Ser422 by TORC1 is almost certainly an artefact.
###end p 62
###begin title 63
Significance of findings from the present study
###end title 63
###begin p 64
###xml 367 370 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">435</sup>
###xml 487 489 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 605 607 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 608 610 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1498 1500 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1590 1592 1562 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1803 1811 1771 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1817 1819 1785 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1972 1973 1924 1925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2135 2137 2083 2085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 2373 2375 2305 2307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 2477 2479 2409 2411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 1955 1959 <span type="species:ncbi:10090">mice</span>
Recently, studies of renal epithelial have indicated that alpha-ENaC transcription may be inhibited by a repressor complex [Dot1a (disruptor of telomeric silencing alternative splice variant a)/Af9 (ALL-1 fused gene from chromosome 9)] that associates with the alpha-ENaC gene promoter. This complex appears to be a substrate for SGK1, which phosphorylates Af9 at Ser435 thus allowing Dot1a to dissociate from this gene region and this, in turn, seems to permit unimpeded transcription [38]. It was therefore suggested that SGK1 is centrally important to the hormonal control of alpha-ENaC transcription [14,38], and this mechanism could explain the augmentation of the glucocorticoid-induced alpha-ENaC transcription that we observe in cells expressing SGK1-S422D or CD2-P110alpha. However, it is important to remember that transient expression of such constitutively active proteins would almost certainly cause hyperactivation of SGK1/PI3K, and it is therefore interesting that our results also show that dexamethasone can activate the alpha-ENaC gene promoter even when signalling via SGK1/PI3K has been blocked. Moreover, although irradiation with UV light increased the activity of endogenous SGK1 via a pathophysiological mechanism, this manoeuvre did not alter the activity of the alpha-ENaC reporter gene construct in unstimulated or dexamethasone-stimulated cells. Although it is abundantly clear that glucocorticoids do activate SGK1 in H441 cells (as shown in the present study and in [24]), the results from the present study, in contrast with those presented by Zhang et al. [38], suggest that this kinase can only play a very minor role in the hormonal control of alpha-ENaC transcription. It is therefore interesting that the quantification of mRNA levels presented by Zhang et al. (see Figure 6E in [38]) show that sgk1 gene deletion has only a modest (approximately30% inhibition) effect upon alpha-ENaC mRNA abundance in the kidneys of mice fed a low-Na+ diet. This result, in common with the results from the present study, indicates that substantial alpha-ENaC gene transcription must occur independently of SGK1 [38]. Moreover, in the lungs, alpha-ENaC gene deletion prevents the absorption of alveolar fluid that normally occurs during the perinatal period and thus causes death through severe respiratory distress within approximately48 h of birth [48]. Genetic deletion of the sgk1 gene, on the other hand, does not cause an overt pulmonary phenotype [49], indicating that at least some alpha-ENaC gene transcription must be able to occur independently of this kinase.
###end p 64
###begin title 65
AUTHOR CONTRIBUTION
###end title 65
###begin p 66
The experimental work was jointly undertaken by Niall McTavish and Jennet Getty. Ann Burchell and Stuart Wilson were primarily responsible for the design of the study and the initial drafting of the manuscript. All authors contributed to the study by joining in discussions of experimental data and by suggesting improvements to the design of individual experiments. All authors also contributed to the revision/editing of the manuscript and approved the final version.
###end p 66
###begin title 67
ACKNOWLEDGEMENTS
###end title 67
###begin p 68
We thank Philip Cohen and Doreen Cantrell (College of Life Sciences, University of Dundee, Dundee, U.K.) for the provision of plasmid constructs and for their valuable advice concerning their use.
###end p 68
###begin title 69
FUNDING
###end title 69
###begin p 70
###xml 31 55 31 55 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs1">Medical Research Council</funding-source>
###xml 70 78 70 78 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="gs1">G0501531</award-id>
###xml 109 123 109 123 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs2">Wellcome Trust</funding-source>
###xml 138 151 138 151 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="gs2">058483/Z/99/Z</award-id>
###xml 171 187 171 187 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs3">Tenovus Scotland</funding-source>
This work was supported by the Medical Research Council [grant number G0501531 (to S. M. W. and A. B.)], the Wellcome Trust [grant number 058483/Z/99/Z (to S. M. W.)] and Tenovus Scotland (to S. M. W. and A. B.).
###end p 70
###begin article-title 71
Synergistic action of triiodothyronine and hydrocortisone on epinephrine-induced reabsorption of fetal lung liquid
###end article-title 71
###begin article-title 72
Clearance of lung fluid during the perinatal period
###end article-title 72
###begin article-title 73
Developmental regulation of lung liquid transport
###end article-title 73
###begin article-title 74
Active transport of sodium as the source of electric current in the short circuited isolated frog skin
###end article-title 74
###begin article-title 75
Epithelial sodium channel related to proteins involved in neurodegeneration
###end article-title 75
###begin article-title 76
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits
###end article-title 76
###begin article-title 77
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
cAMP and serum and glucocorticoid-inducible kinase (SGK) regulate the epithelial Na+ channel through convergent phosphorylation of Nedd4-2
###end article-title 77
###begin article-title 78
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The epithelial Na+ channel: cell surface insertion and retrieval in Na+ homeostasis and hypertension
###end article-title 78
###begin article-title 79
SGK kinases and their role in epithelial transport
###end article-title 79
###begin article-title 80
Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms
###end article-title 80
###begin article-title 81
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Structure and hormone responsiveness of the gene encoding the alpha-subunit of the rat amiloride-sensitive epithelial sodium channel
###end article-title 81
###begin article-title 82
###xml 178 181 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
The alpha-subunit of the epithelial sodium channel is an aldosterone-induced transcript in mammalian collecting ducts, and this transcriptional response is mediated via distinct cis-elements in the 5'-flanking region of the gene
###end article-title 82
###begin article-title 83
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 184 189 <span type="species:ncbi:9606">human</span>
Glucocorticoid induction of epithelial sodium channel expression in lung and renal epithelia occurs via trans-activation of a hormone response element in the 5'-flanking region of the human epithelial sodium channel alpha subunit gene
###end article-title 83
###begin article-title 84
Gene regulation of ENaC subunits by serum- and glucocorticoid-inducible kinase-1
###end article-title 84
###begin article-title 85
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 44 49 <span type="species:ncbi:9606">human</span>
A glucocorticoid-induced Na+ conductance in human airway epithelial cells identified by perforated patch recording
###end article-title 85
###begin article-title 86
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 76 <span type="species:ncbi:9606">human</span>
The regulation of selective and non-selective Na+ conductances in H441 human airway epithelial cells
###end article-title 86
###begin article-title 87
Activation of serum- and glucocorticoid-regulated protein kinases by agonists that activate phosphatidylinositol 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase 1 (PDK1) and PDK2
###end article-title 87
###begin article-title 88
Phosphatidylinositol 3-kinsase signals activate a selective subset of Rac/Rho-dependent effector pathways
###end article-title 88
###begin article-title 89
Exploitation of KESTREL to identify NDRG family members as physiological substrates of SGK1 and GSK3
###end article-title 89
###begin article-title 90
Identification of different specificity requirements between SGK1 and PKBalpha
###end article-title 90
###begin article-title 91
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 92 103 92 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346/356/366</sup>
###xml 31 36 <span type="species:ncbi:9606">human</span>
SGK1 activity in Na+ absorbing human airway epithelial cells monitored by assaying NDRG1-Thr346/356/366 phosphorylation
###end article-title 91
###begin article-title 92
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-inducible protein kinase 1 (SGK1)
###end article-title 92
###begin article-title 93
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Thyroid hormone potentiates glucocorticoid-evoked airway Na+ transport without affecting alpha-ENaC transcription
###end article-title 93
###begin article-title 94
Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway
###end article-title 94
###begin article-title 95
(Patho)physiological significance of the serum and glucocorticoid-inducible kinase isoforms
###end article-title 95
###begin article-title 96
###xml 43 48 <span type="species:ncbi:9606">human</span>
Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations in cell volume
###end article-title 96
###begin article-title 97
Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells
###end article-title 97
###begin article-title 98
p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1
###end article-title 98
###begin article-title 99
Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein
###end article-title 99
###begin article-title 100
The selectivity of protein kinase inhibitors: a further update
###end article-title 100
###begin article-title 101
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sgk1</italic>
Glucocorticoid-stimulated lung epithelial Na+ transport is associated with regulated ENaC and sgk1 expression
###end article-title 101
###begin article-title 102
###xml 83 88 <span type="species:ncbi:9606">human</span>
Oxygen-evoked changes in transcriptional activity of the 5'-flanking region of the human amiloride-sensitive sodium channel (alphaENaC) gene: role of nuclear factor kappaB
###end article-title 102
###begin article-title 103
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
A polymorphism in the glucocorticoid receptor gene may be associated with increased sensitivity to glucocorticoids in vivo
###end article-title 103
###begin article-title 104
Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia
###end article-title 104
###begin article-title 105
###xml 114 120 <span type="species:ncbi:9606">humans</span>
Kinetic-dynamic modeling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone
###end article-title 105
###begin article-title 106
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Aldoseroneinduced Sgk1 relieves Dot1a-Af9-mediated transcriptional repression of epithelial Na+ channel alpha
###end article-title 106
###begin article-title 107
Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase
###end article-title 107
###begin article-title 108
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions
###end article-title 108
###begin article-title 109
An amphipathic helix targets serum and glucocorticoid-induced kinase 1 to the endoplasmic reticulum-associated ubiquitin-conjugation machinery
###end article-title 109
###begin article-title 110
Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways
###end article-title 110
###begin article-title 111
The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover
###end article-title 111
###begin article-title 112
Differential regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) splice variants based on alternative initiation of transcription
###end article-title 112
###begin article-title 113
Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
###end article-title 113
###begin article-title 114
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
###end article-title 114
###begin article-title 115
mTOR-Raptor binds and activates SGK1 to regulate p27 phosphorylation
###end article-title 115
###begin article-title 116
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice
###end article-title 116
###begin article-title 117
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Impaired renal Na+ retention in the sgk1-knockout mouse
###end article-title 117

